NURS 6521 Final Exam 2025/2026 V3 Winter
Quarter Walden University | Advanced
Pharmacology | Complete Exam with Accurate
Questions & Answers
NURS 6521 Advanced Pharmacology Final Exam | Key Concepts: Pharmacokinetics,
Pharmacodynamics, Prescriptive Authority, Major Drug Classes, Adverse Effects, Drug
Interactions, Evidence-Based Prescribing, and Patient Safety | Expert-Verified Q&A | Clinical &
Exam-Ready
Introduction
This updated 2025/2026 NURS 6521 Advanced Pharmacology Final Exam (Version 3 – Winter
Quarter, Walden University) resource contains 100 fully verified questions with correct answers,
designed to reflect the exam’s focus on advanced pharmacology. Content covers
pharmacokinetics and pharmacodynamics (20%, 20 questions), major drug classes and
therapeutic uses (25%, 25 questions), adverse effects and drug interactions (20%, 20 questions),
prescriptive authority and evidence-based prescribing (20%, 20 questions), and patient safety
and education (15%, 15 questions). All answers are graded A+ and include rationales to reinforce
clinical judgment, safe prescribing practices, and exam readiness.
Answer Format
Correct answers are highlighted in bold and green, with rationales explaining pharmacologic
principles, safe prescribing practices, and clinical decision-making skills.
NURS 6521 Final Exam Questions (1–100)
Pharmacokinetics and Pharmacodynamics (20 questions)
1. What is the primary site of drug metabolism in the body?
a) Kidneys
b) Liver
c) Lungs
d) Stomach
b) Liver
Rationale: The liver is the primary organ for drug metabolism, primarily via the cytochrome
P450 enzyme system, which transforms drugs into metabolites for excretion.
2. What does the term 'half-life' of a drug refer to?
a) Time to reach peak concentration
,b) Time for drug concentration to reduce by half
c) Time for complete drug elimination
d) Time for drug absorption
b) Time for drug concentration to reduce by half
Rationale: Half-life is the time required for the plasma concentration of a drug to decrease by
50%, influencing dosing frequency.
3. Which factor most affects drug bioavailability?
a) First-pass metabolism
b) Drug half-life
c) Plasma protein binding
d) Renal excretion
a) First-pass metabolism
Rationale: First-pass metabolism in the liver reduces the amount of active drug reaching
systemic circulation, affecting bioavailability.
4. What is the primary mechanism of action of beta-blockers?
a) Inhibit ACE
b) Block beta-adrenergic receptors
c) Block calcium channels
d) Inhibit sodium reabsorption
b) Block beta-adrenergic receptors
Rationale: Beta-blockers reduce heart rate and contractility by blocking beta-adrenergic
receptors, decreasing sympathetic activity.
5. What does the term 'therapeutic index' describe?
a) Drug potency
b) Ratio of toxic dose to effective dose
c) Drug absorption rate
d) Drug metabolism rate
b) Ratio of toxic dose to effective dose
Rationale: The therapeutic index measures a drug’s safety margin, with a higher index
indicating safer drugs.
6. Which route of administration bypasses first-pass metabolism?
a) Oral
b) Intravenous
c) Rectal
d) Sublingual
b) Intravenous
Rationale: Intravenous administration delivers drugs directly into the bloodstream, avoiding
liver metabolism.
7. What is the primary effect of a competitive antagonist?
a) Enhances receptor activity
b) Blocks receptor binding
, c) Increases drug metabolism
d) Prolongs drug half-life
b) Blocks receptor binding
Rationale: Competitive antagonists bind to receptors, preventing agonists from exerting their
effects.
8. Which organ is primarily responsible for drug excretion?
a) Liver
b) Kidneys
c) Lungs
d) Skin
b) Kidneys
Rationale: The kidneys filter and excrete most drugs and their metabolites via urine.
9. What is the effect of cytochrome P450 enzyme induction?
a) Slows drug metabolism
b) Increases drug metabolism
c) Reduces drug absorption
d) Prolongs drug action
b) Increases drug metabolism
Rationale: Enzyme induction increases P450 activity, accelerating drug metabolism and
reducing drug effects.
10. What is the primary action of an agonist?
a) Blocks receptor activity
b) Mimics endogenous ligand
c) Inhibits drug metabolism
d) Reduces drug absorption
b) Mimics endogenous ligand
Rationale: Agonists bind to receptors and mimic the effects of natural ligands, activating the
receptor.
11. How does renal impairment affect drug clearance?
a) Increases clearance
b) Decreases clearance
c) No effect on clearance
d) Increases absorption
b) Decreases clearance
Rationale: Renal impairment reduces the kidneys’ ability to excrete drugs, prolonging their
effects.
12. What is the primary effect of a drug with high protein binding?
a) Increased bioavailability
b) Reduced free drug levels
c) Faster metabolism
d) Enhanced excretion
Quarter Walden University | Advanced
Pharmacology | Complete Exam with Accurate
Questions & Answers
NURS 6521 Advanced Pharmacology Final Exam | Key Concepts: Pharmacokinetics,
Pharmacodynamics, Prescriptive Authority, Major Drug Classes, Adverse Effects, Drug
Interactions, Evidence-Based Prescribing, and Patient Safety | Expert-Verified Q&A | Clinical &
Exam-Ready
Introduction
This updated 2025/2026 NURS 6521 Advanced Pharmacology Final Exam (Version 3 – Winter
Quarter, Walden University) resource contains 100 fully verified questions with correct answers,
designed to reflect the exam’s focus on advanced pharmacology. Content covers
pharmacokinetics and pharmacodynamics (20%, 20 questions), major drug classes and
therapeutic uses (25%, 25 questions), adverse effects and drug interactions (20%, 20 questions),
prescriptive authority and evidence-based prescribing (20%, 20 questions), and patient safety
and education (15%, 15 questions). All answers are graded A+ and include rationales to reinforce
clinical judgment, safe prescribing practices, and exam readiness.
Answer Format
Correct answers are highlighted in bold and green, with rationales explaining pharmacologic
principles, safe prescribing practices, and clinical decision-making skills.
NURS 6521 Final Exam Questions (1–100)
Pharmacokinetics and Pharmacodynamics (20 questions)
1. What is the primary site of drug metabolism in the body?
a) Kidneys
b) Liver
c) Lungs
d) Stomach
b) Liver
Rationale: The liver is the primary organ for drug metabolism, primarily via the cytochrome
P450 enzyme system, which transforms drugs into metabolites for excretion.
2. What does the term 'half-life' of a drug refer to?
a) Time to reach peak concentration
,b) Time for drug concentration to reduce by half
c) Time for complete drug elimination
d) Time for drug absorption
b) Time for drug concentration to reduce by half
Rationale: Half-life is the time required for the plasma concentration of a drug to decrease by
50%, influencing dosing frequency.
3. Which factor most affects drug bioavailability?
a) First-pass metabolism
b) Drug half-life
c) Plasma protein binding
d) Renal excretion
a) First-pass metabolism
Rationale: First-pass metabolism in the liver reduces the amount of active drug reaching
systemic circulation, affecting bioavailability.
4. What is the primary mechanism of action of beta-blockers?
a) Inhibit ACE
b) Block beta-adrenergic receptors
c) Block calcium channels
d) Inhibit sodium reabsorption
b) Block beta-adrenergic receptors
Rationale: Beta-blockers reduce heart rate and contractility by blocking beta-adrenergic
receptors, decreasing sympathetic activity.
5. What does the term 'therapeutic index' describe?
a) Drug potency
b) Ratio of toxic dose to effective dose
c) Drug absorption rate
d) Drug metabolism rate
b) Ratio of toxic dose to effective dose
Rationale: The therapeutic index measures a drug’s safety margin, with a higher index
indicating safer drugs.
6. Which route of administration bypasses first-pass metabolism?
a) Oral
b) Intravenous
c) Rectal
d) Sublingual
b) Intravenous
Rationale: Intravenous administration delivers drugs directly into the bloodstream, avoiding
liver metabolism.
7. What is the primary effect of a competitive antagonist?
a) Enhances receptor activity
b) Blocks receptor binding
, c) Increases drug metabolism
d) Prolongs drug half-life
b) Blocks receptor binding
Rationale: Competitive antagonists bind to receptors, preventing agonists from exerting their
effects.
8. Which organ is primarily responsible for drug excretion?
a) Liver
b) Kidneys
c) Lungs
d) Skin
b) Kidneys
Rationale: The kidneys filter and excrete most drugs and their metabolites via urine.
9. What is the effect of cytochrome P450 enzyme induction?
a) Slows drug metabolism
b) Increases drug metabolism
c) Reduces drug absorption
d) Prolongs drug action
b) Increases drug metabolism
Rationale: Enzyme induction increases P450 activity, accelerating drug metabolism and
reducing drug effects.
10. What is the primary action of an agonist?
a) Blocks receptor activity
b) Mimics endogenous ligand
c) Inhibits drug metabolism
d) Reduces drug absorption
b) Mimics endogenous ligand
Rationale: Agonists bind to receptors and mimic the effects of natural ligands, activating the
receptor.
11. How does renal impairment affect drug clearance?
a) Increases clearance
b) Decreases clearance
c) No effect on clearance
d) Increases absorption
b) Decreases clearance
Rationale: Renal impairment reduces the kidneys’ ability to excrete drugs, prolonging their
effects.
12. What is the primary effect of a drug with high protein binding?
a) Increased bioavailability
b) Reduced free drug levels
c) Faster metabolism
d) Enhanced excretion
